Core Viewpoint - Awei Technology Co., Ltd. has announced that its wholly-owned subsidiary, Hunan Awei Medical Testing Co., Ltd., has obtained a medical institution practice license, allowing it to provide third-party medical testing services, which is expected to create a new growth point for the company [1][2]. Group 1: License Acquisition - Hunan Awei Medical Testing Co., Ltd. received the medical institution practice license from the Health and Health Bureau of Hunan Xiangjiang New District [1]. - The license is valid from November 4, 2025, to November 3, 2030, and covers various diagnostic specialties including clinical microbiology and clinical chemistry [1]. Group 2: Impact on Business - The acquisition of the license enables the company to integrate its existing testing instruments and reagents with testing services, promoting a "device + service" business model [2]. - The impact on the company's performance post-launch of the testing laboratory remains uncertain due to factors such as industry supply and demand, market competition, and brand promotion [2]. Group 3: Investor Communication - The company will hold a third-quarter performance briefing on November 24, 2025, to discuss its operational results and financial status, allowing investors to engage in Q&A [6][7]. - Investors can submit questions from November 17 to November 21, 2025, through the Shanghai Stock Exchange Roadshow Center [8].

Core Viewpoint - Aiwei Technology (688067.SH) has received a medical institution practice license for its wholly-owned subsidiary, Hunan Aiwei Medical Laboratory Co., Ltd., allowing it to officially provide third-party medical testing services, which opens new business growth opportunities and integrates existing testing instruments and reagents with testing services into a "device + service" business model [1]. Company Summary - Hunan Aiwei Medical Laboratory Co., Ltd. has obtained the "Medical Institution Practice License" issued by the Health and Health Bureau of Hunan Xiangjiang New Area [1]. - The licensed diagnostic specialties include: medical laboratory, clinical body fluids and blood, clinical microbiology, clinical chemical testing, clinical immunology and serology, and clinical cellular molecular genetics [1]. - The new license enables the company to offer third-party medical testing services, enhancing its business model by integrating testing equipment and services [1].

Core Viewpoint - Aiwei Technology (688067.SH) has received a medical institution practice license for its wholly-owned subsidiary, Hunan Aiwei Medical Laboratory Co., Ltd, enabling it to provide third-party medical testing services, which will create new business growth opportunities and integrate existing testing instruments and reagents with testing services into a "device + service" business model [1] Group 1 - The company has obtained a medical institution practice license from the Hunan Xiangjiang New Area Health Bureau [1] - Hunan Aiwei Medical Laboratory Co., Ltd will officially offer third-party medical testing services [1] - This development is expected to open new business growth points for the company [1] Group 2 - The integration of existing testing instruments and reagents with testing services will enhance the company's offerings [1] - The company aims to create a comprehensive "device + service" business model [1]

Core Viewpoint - Aiwei Technology (688067.SH) has received a medical institution practice license for its wholly-owned subsidiary, Hunan Aiwei Medical Laboratory Co., Ltd, enabling it to officially provide third-party medical testing services [1] Group 1: Business Expansion - The acquisition of the medical institution practice license opens a new growth avenue for the company [1] - This development allows for the integration of existing testing instruments and reagent consumables with testing services, creating a "device + service" integrated business model [1]

Core Viewpoint - The company has received a medical institution practice license for its subsidiary, which will enable it to provide third-party medical testing services, thus creating new business growth opportunities and promoting an integrated "equipment + service" business model [1] Group 1 - The subsidiary, Hunan Aiwei Medical Testing Co., Ltd., has obtained a medical institution practice license from the Hunan Xiangjiang New Area Health and Health Bureau [1] - The license is valid from November 4, 2025, to November 3, 2030, for the facility named Changsha Aiwei Medical Testing Laboratory [1] - The acquisition of this license will allow the company to officially offer third-party medical testing services [1]